Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment ...

This study by Hanlon and colleagues identified primarily age-related heterogeneity in the effects of SGLT2 inhibitors and GLP-1s on glycemic control and major adverse cardiovascular events ...

A new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...

Slight body weight and systolic blood pressure reduction are important beneficial effects. Main adverse events of SGLT2 inhibitors are genital mycotic and urinary tract infections. Dapagliflozin ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

SGLT2 inhibitors help lower blood sugar by ... Like all drugs, Farxiga carries the potential for adverse effects. Therefore, monitor yourself or a loved one for side effects, especially those ...

The study revealed a lower risk of nephrolithiasis with SGLT2 inhibitors than DPP4 inhibitors in both stone never-formers and ...

SGLT2 inhibitors and GLP-1 agonists also reduced the risk of major adverse cardiovascular events ... despite the glucose lowering effects being less in older people,” he noted. SGLT2 inhibitors were ...

CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves ...

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...